READ

AI will see you now

How AI is transforming healthcare.
Karl Gruber
Karl Gruber
Freelance Science Writer
AI will see you now

As you read this, AI is being used to detect and diagnose disease, enhance treatment efficiency and develop new drugs.

By recognising patterns in test results, AI can identify patients at risk of cancer, diabetes complications, heart disease and mental health issues. 

Trained AI systems can match or outperform radiologists at detecting cancers and analysing chest X-rays, mammograms and CT brain scans.

These systems provide an extra set of eyes, flagging suspicious spots for review.

AI in Action

Professor Anant Madabhushi is Director of the Emory Empathetic AI for Health Institute at Emory University in the USA.

“One of the most exciting applications is using AI to analyse medical images – like MRI scans, CT scans or pathology slides – to find patterns that doctors may not easily see,” says Anant. 

Caption: Anant Madabhushi is using AI as an ‘extra set of eyes’ in medicine.
Credit: via Emory University

“For instance, AI can help detect cancer earlier or predict which patients are more likely to benefit from certain treatments.

“These tools don’t replace doctors but act like an extra set of eyes, making medicine more precise and personalised.”

Beyond Diagnosis

AI can do more than detect disease – it’s improving doctors’ treatment decisions. 

Charles Darwin University researchers have created an AI model that examines lung ultrasound videos. It can diagnose pneumonia, COVID-19 and other respiratory diseases with 97% accuracy. 

“Imagine if, based on a patient’s scans and lab results, AI could suggest which therapy is most likely to work for that specific person,” says Anant. 

“That’s better for patients and helps doctors make decisions faster and more confidently. 

“It also has the potential to free doctors from routine tasks, giving them more time to focus on patient care.”

Work smarter, not harder

AI tools can also save patients time and money.

IDx-DR can scan eye images to detect diabetic retinopathy – one of the leading causes of blindness in people with diabetes.

These instant results can be provided in a GP clinic instead of requiring a specialist appointment.

Heartflow’s FFRCT can diagnose heart disease. These systems can turn ordinary CT scans into 3D models of blood flow, allowing doctors to spot dangerous blockages without invasive procedures. 

Caption: AI can help detect blockages in blood vessels from CT scans, rather than using invasive procedures.
Credit: Dominika Zarzycka/NurPhoto/Getty Images

AI can even help researchers design new drugs. Developing medications typically takes over a decade and costs billions of dollars. But using AI platforms to quickly analyse massive datasets and pinpoint promising molecules can cut timelines from years to just 30 days, according to pharmaceutical giant Pfizer.

AI can predict how molecules will behave in someone’s body and design smarter clinical trials by selecting patients who are more likely to respond well to the drugs being tested.

These automated systems can also forecast side effects and adjust the trial midway if early data suggests changes are needed. 

Tools like TrialMatchAI can rapidly match patients to trials with greater accuracy. Other AI systems are modelling how new molecules move through the body to predict safety issues before patients are enrolled. Pharmaceutical companies have already begun using these tools. 

WA INNOVATION

In January, the WA Government announced nearly $5 million in funding for digital health projects, many of which harness AI. 

Grant recipient Professor Girish Dwivedi has created a personalised health platform called Orva. Orva can explain complex medical information in plain language and aims to engage patients in their treatment.

Another recipient, Associate Professor Matthew Anstey, is developing a potentially life-saving AI system that predicts sepsis in emergency departments.

UWA lecturer Dr Jake Kendrick is advancing AI tools for prostate cancer imaging.

Caption: Jake Kendrick (centre) with colleagues Nathaniel Barry (left) and Brani Rusanov (right).
Credit: Supplied Jake Kendrick

“My research focuses on using artificial intelligence to automatically outline and measure cancer on PSMA PET scans – a type of medical imaging used for prostate cancer,” says Jake. 

“By training AI to do this quickly and consistently, we hope to give clinicians better tools to guide treatment decisions.

“Ultimately, this could help prostate cancer patients receive more personalised care, allowing better prediction of treatment effectiveness.”

Whilst trained medical professionals still make the decisions, AI can help them make smarter, more patient-focused decisions to improve the health and wellbeing of West Aussies.

Why all of This Matters

From saving valuable time in disease diagnosis to shaving years off drug development, AI is quietly transforming healthcare. 

It doesn’t replace doctors or scientists. It works alongside them, handling data-heavy tasks so they can focus on patient care. 

While it’s still early days, it’s clear that a global healthcare revolution has begun. 

Karl Gruber
About the author
Karl Gruber
Karl is an Evolutionary Biologist and a science communicator, passionate about the beauty behind science.
View articles
Karl is an Evolutionary Biologist and a science communicator, passionate about the beauty behind science.
View articles

NEXT ARTICLE

We've got chemistry, let's take it to the next level!

Get the latest WA science news delivered to your inbox, every fortnight.

This field is for validation purposes and should be left unchanged.

Republish

Creative Commons Logo

Republishing our content

We want our stories to be shared and seen by as many people as possible.

Therefore, unless it says otherwise, copyright on the stories on Particle belongs to Scitech and they are published under a Creative Commons Attribution-NoDerivatives 4.0 International License.

This allows you to republish our articles online or in print for free. You just need to credit us and link to us, and you can’t edit our material or sell it separately.

Using the ‘republish’ button on our website is the easiest way to meet our guidelines.

Guidelines

You cannot edit the article.

When republishing, you have to credit our authors, ideally in the byline. You have to credit Particle with a link back to the original publication on Particle.

If you’re republishing online, you must use our pageview counter, link to us and include links from our story. Our page view counter is a small pixel-ping (invisible to the eye) that allows us to know when our content is republished. It’s a condition of our guidelines that you include our counter. If you use the ‘republish’ then you’ll capture our page counter.

If you’re republishing in print, please email us to let us so we know about it (we get very proud to see our work republished) and you must include the Particle logo next to the credits. Download logo here.

If you wish to republish all our stories, please contact us directly to discuss this opportunity.

Images

Most of the images used on Particle are copyright of the photographer who made them.

It is your responsibility to confirm that you’re licensed to republish images in our articles.

Video

All Particle videos can be accessed through YouTube under the Standard YouTube Licence.

The Standard YouTube licence

  1. This licence is ‘All Rights Reserved’, granting provisions for YouTube to display the content, and YouTube’s visitors to stream the content. This means that the content may be streamed from YouTube but specifically forbids downloading, adaptation, and redistribution, except where otherwise licensed. When uploading your content to YouTube it will automatically use the Standard YouTube licence. You can check this by clicking on Advanced Settings and looking at the dropdown box ‘License and rights ownership’.
  2. When a user is uploading a video he has license options that he can choose from. The first option is “standard YouTube License” which means that you grant the broadcasting rights to YouTube. This essentially means that your video can only be accessed from YouTube for watching purpose and cannot be reproduced or distributed in any other form without your consent.

Contact

For more information about using our content, email us: particle@scitech.org.au

Copy this HTML into your CMS
Press Ctrl+C to copy